What is amazing is that NanoLogix today has received Wash Post mention favorably, had a good story come out in the Vindicator, had the suggestion that it continues to build the range and scale of its customer base, has extremely critical technology related to rapid detection of Ebola and Enterovirus as well as the developments with the N-Assay in neonatal care and MRSA of which we are aware. And the share price declined so far today. It obviously must be management's fault? Deep breaths everyone.